- Fibrocell Science (NASDAQ:FCSC) is up 64% premarket on light volume in reaction to its agreement to be acquired by collaboration partner Castle Creek Pharmaceutical Holdings for an undisclosed sum.
- Both companies are developing therapies to treat a rare skin disorder called epidermolysis bullosa.
Date: September 16, 2019
Source: AwesomeCapital